Author: Hanazawa Tomohiro Obara Taku Ogasawara Kei Shinki Takahiro Katada Sakiko Inoue Ryusuke Metoki Hirohito Asayama Kei Kikuya Masahiro Ohkubo Takayoshi Mano Nariyasu Imai Yutaka
Publisher: Informa Healthcare
ISSN: 1064-1963
Source: Clinical and Experimental Hypertension, Vol.33, Iss.7, 2011-11, pp. : 427-436
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Satoh Michihiro Obara Taku Ikeda Urara Kobayashi Yuka Metoki Hirohito Asayama Kei Kikuya Masahiro Ohkubo Takayoshi Department of Planning for Drug Development and Clinical Evaluation Tohoku University Graduate School of Pharmaceutical Sciences Yutaka
Clinical and Experimental Hypertension, Vol. 34, Iss. 4, 2012-07 ,pp. :
By Makita Shinji Abiko Akihiko Naganuma Yujirou Tamada Makiko Nakamura Motoyuki
Clinical and Experimental Hypertension, Vol. 31, Iss. 2, 2009-04 ,pp. :
The rationale for low-dose hormonal therapy
By Lobo Rogerio
Endocrine Journal, Vol. 24, Iss. 3, 2004-08 ,pp. :
By Okura Takafumi Miyoshi Ken-ichi Irita Jun Enomoto Daijiro Jotoku Masanori Nagao Tomoaki Watanabe Kouki Matsuoka Hiroshi Ashihara Toshiaki Higaki Jitsuo
Clinical and Experimental Hypertension, Vol. 35, Iss. 8, 2013-12 ,pp. :